Gunderson Dettmer represented RadioMedix on the deal. RadioMedix announced its $40 million equity financing led by Portland Investment Counsel Inc. RadioMedix is a clinical-stage biotech focused ontargeted radiopharmaceuticals...
This content is for Standard 1 Year members only. LoginJoin Now